| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | AZD7762 | CTRPv2 | pan-cancer | AAC | -0.035 | 0.3 |
| mRNA | Vandetanib | CCLE | pan-cancer | AAC | 0.05 | 0.3 |
| mRNA | BRD1812 | CTRPv2 | pan-cancer | AAC | 0.038 | 0.3 |
| mRNA | LFM-A13 | GDSC1000 | pan-cancer | AAC | -0.04 | 0.3 |
| mRNA | FK866 | GDSC1000 | pan-cancer | AAC | -0.036 | 0.3 |
| mRNA | purmorphamine | CTRPv2 | pan-cancer | AAC | 0.04 | 0.3 |
| mRNA | compound 1B | CTRPv2 | pan-cancer | AAC | -0.041 | 0.3 |
| mRNA | Ispinesib Mesylate | GDSC1000 | pan-cancer | AAC | 0.036 | 0.3 |
| mRNA | MS-275 | FIMM | pan-cancer | AAC | -0.15 | 0.3 |
| mRNA | I-BET-762 | GDSC1000 | pan-cancer | AAC | 0.031 | 0.3 |